<html xmlns:mims="http://www.mims.com"><head><link type="text/css" href="css/redmond/jquery-ui-1.8.6.custom.css" rel="stylesheet" /><link type="text/css" href="css/mims.css" rel="stylesheet" /><script type="text/javascript" src="scripts/jquery-1.4.4.min.js"></script><script type="text/javascript" src="scripts/jquery-ui-1.8.6.custom.min.js"></script><script type="text/javascript" src="scripts/monograph.js"></script></head><body><div id="tabs"><ul><li><a href="#tab-generic">Generic</a></li></ul><div id="tab-generic"><h4 class="subheading"></h4><table class="ui-widget monograph"><tr><td class="monograph-heading ui-widget-content"><span style="font-weight: bold">Dosage</span></td><td class="ui-widget-content"><I>Oral</I><BR><B>Sprains</B><BR><B><I>Adult: </I></B>As sodium: 75-150 mg daily in divided doses. Max: 150 mg/day.<BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Oral</I><BR><B>Strains</B><BR><B><I>Adult: </I></B>As sodium: 75-150 mg daily in divided doses. Max: 150 mg/day.<BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Oral</I><BR><B> Tendinitis</B><BR><B><I>Adult: </I></B>As sodium: 75-150 mg daily in divided doses. Max: 150 mg/day.<BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Oral</I><BR><B> Pain and inflammation associated with musculoskeletal and joint disorders</B><BR><B><I>Adult: </I></B>As sodium: 75-150 mg daily in divided doses. Max: 150 mg/day.<BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Oral</I><BR><B> Bursitis</B><BR><B><I>Adult: </I></B>As sodium: 75-150 mg daily in divided doses. Max: 150 mg/day.<BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Oral</I><BR><B>Acute gout</B><BR><B><I>Adult: </I></B>As sodium: 75-150 mg daily in divided doses. Max: 150 mg/day.<BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Oral</I><BR><B> Dysmenorrhoea</B><BR><B><I>Adult: </I></B>As sodium: 75-150 mg daily in divided doses. Max: 150 mg/day.<BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Oral</I><BR><B> Migraine</B><BR><B><I>Adult: </I></B>As potassium: Initially, 50 mg taken at the 1st sign of an attack, an additional dose of 50 mg may be taken after 2 hr if symptoms persist. If needed, further doses of 50 mg may be taken every 4-6 hr. Max: 200 mg/day. <BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Intravenous</I><BR><B>Postoperative pain</B><BR><B><I>Adult: </I></B>As sodium: 75 mg infusion in 5% glucose or 0.9% sodium chloride given over 30-120 minutes, may repeat after 4-6 hr if necessary.<BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Intramuscular</I><BR><B>Bursitis</B><BR><B><I>Adult: </I></B>As sodium: 75 mg once daily, injected into the gluteal muscle, may increase to 75 mg bid in severe conditions.<BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Intramuscular</I><BR><B>Sprains</B><BR><B><I>Adult: </I></B>As sodium: 75 mg once daily, injected into the gluteal muscle, may increase to 75 mg bid in severe conditions.<BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Intramuscular</I><BR><B>Strains</B><BR><B><I>Adult: </I></B>As sodium: 75 mg once daily, injected into the gluteal muscle, may increase to 75 mg bid in severe conditions.<BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Intramuscular</I><BR><B>Tendinitis</B><BR><B><I>Adult: </I></B>As sodium: 75 mg once daily, injected into the gluteal muscle, may increase to 75 mg bid in severe conditions.<BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Intramuscular</I><BR><B>Pain and inflammation associated with musculoskeletal and joint disorders</B><BR><B><I>Adult: </I></B>As sodium: 75 mg once daily, injected into the gluteal muscle, may increase to 75 mg bid in severe conditions.<BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Intramuscular</I><BR><B>Acute gout</B><BR><B><I>Adult: </I></B>As sodium: 75 mg once daily, injected into the gluteal muscle, may increase to 75 mg bid in severe conditions.<BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Intramuscular</I><BR><B>Dysmenorrhoea</B><BR><B><I>Adult: </I></B>As sodium: 75 mg once daily, injected into the gluteal muscle, may increase to 75 mg bid in severe conditions.<BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Intramuscular</I><BR><B>Renal colic</B><BR><B><I>Adult: </I></B>As sodium: 75 mg, may repeat once after 30 minutes if needed. Max: 150 mg/day.<BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Intravenous</I><BR><B>Prophylaxis of postoperative pain</B><BR><B><I>Adult: </I></B>As sodium: 25-50 mg infusion given after surgery over 15-60 minutes followed by 5 mg/hr. Max: 150 mg daily.<BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Ophthalmic</I><BR><B>Postoperative ocular inflammation</B><BR><B><I>Adult: </I></B>As sodium (0.1% solution): Instill into the appropriate eye 4 times daily starting 24 hr after surgery for up to 28 days.<BR><I>Ophthalmic</I><BR><B>Prophylaxis of intra-operative miosis</B><BR><B><I>Adult: </I></B>As sodium (0.1% solution): Instill into the appropriate eye 4 times within 2 hr before surgery.<BR><I>Ophthalmic</I><BR><B>Post-photorefractive keratectomy pain</B><BR><B><I>Adult: </I></B>As sodium (0.1% solution): Instill into the eye twice in the hr before surgery, then 1 drop twice at 5-minute intervals immediately after surgery, then every 2-5 hr while awake for up to 24 hr.<BR><I>Ophthalmic</I><BR><B>Seasonal allergic conjunctivitis</B><BR><B><I>Adult: </I></B>As sodium (0.1% solution): Instill 1 drop into the affected eye(s) up to 4 times daily. <BR><I>Ophthalmic</I><BR><B>Pain and discomfort after radial keratotomy</B><BR><B><I>Adult: </I></B>As sodium (0.1% solution): Instill 1 drop before surgery followed by 1 drop immediately after surgery, and then 1 drop 4 times daily for up to 2 days.  <BR><I>Ophthalmic</I><BR><B>Control of inflammation after argon laser trabeculoplasty</B><BR><B><I>Adult: </I></B>As sodium (0.1% solution): Instill 1 drop 4 times during the 2 hr before procedure followed by 1 drop 4 times daily,  up to 7 days after procedure. <BR><I>Ophthalmic</I><BR><B>Inflammation and discomfort after strabismus surgery</B><BR><B><I>Adult: </I></B>As sodium (0.1% solution): Instill 1 drop 4 times daily for the 1st wk; then tid in the 2nd wk, bid in the 3rd wk, and as required for the 4th wk. <BR><I>Ophthalmic</I><BR><B>Pain after accidental trauma</B><BR><B><I>Adult: </I></B>As sodium (0.1% solution): Instill 1 drop 4 times daily for up to 2 days. <BR><I>Topical/Cutaneous</I><BR><B>Local symptomatic relief of pain and inflammation</B><BR><B><I>Adult: </I></B>As sodium (1% gel): Apply onto affected area 3-4 times daily. <BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Topical/Cutaneous</I><BR><B> Osteoarthritis</B><BR><B><I>Adult: </I></B>As sodium (1.6% solution): Apply in small amounts (20-40 drops) onto affected area 4 times daily. <BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Topical/Cutaneous</I><BR><B>Actinic keratoses</B><BR><B><I>Adult: </I></B>As sodium (3% gel): Apply bid for 60-90 days. <BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Rectal</I><BR><B>Postoperative pain</B><BR><B><I>Adult: </I></B>75-150 mg daily, in divided doses (25 mg, 50 mg and 100 mg suppositories only). Max: 150 mg/day (inclusive of diclofenac administered through other routes). <BR><B><I>Child: </I></B>6-12 yr: 1-2 mg/kg/day in divided doses (12.5 mg and 25 mg suppositories only) for max of 4 days. <BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed.</td></tr><tr><td class="monograph-heading ui-widget-content"><span style="font-weight: bold">Administration</span></td><td class="ui-widget-content">Should be taken with food. (Take immediately after meals.)<br></td></tr><tr><td class="monograph-heading ui-widget-content"><span style="font-weight: bold">Contraindications</span></td><td class="ui-widget-content">Active peptic ulcer; hypersensitivity to diclofenac or other NSAIDs. Treatment of perioperative pain in CABG surgery. 3rd trimester of pregnancy. Topical: Not to be applied onto damaged or nonintact skin.</td></tr><tr><td class="monograph-heading ui-widget-content"><span style="font-weight: bold">Special precautions</span></td><td class="ui-widget-content">History of GI ulceration; impaired cardiac, renal or hepatic function; hypertension; lactation. IV admin in patients with moderate or severe renal impairment; hypovolaemia or dehydration; asthma, porphyria. Monitor LFTs in patients on prolonged therapy. May prolong bleeding time; caution when used in patients with coagulation disorders or on anticoagulants. Prolonged therapy may increase risk of anaemia. 1st and 2nd trimester of pregnancy. Elderly, debilitated patients.</td></tr><tr><td class="monograph-heading ui-widget-content"><span style="font-weight: bold">Adverse reactions</span></td><td class="ui-widget-content">GI disturbances; headache, dizziness, rash; GI bleeding, peptic ulceration; abnormalities of kidney function. Pain and tissue damage at Inj site (IM); local irritation (rectal); transient burning and stinging (ophthalmic).<BR/> <B>Potentially Life-Threatening Adverse Drug Reaction: </B>Stevens-Johnson syndrome, exfoliative dermatitis, toxic epidermal necrolysis.</td></tr><tr><td class="monograph-heading ui-widget-content"><span style="font-weight: bold">Drug interactions</span></td><td class="ui-widget-content">Not to be given IV to patients who are receiving other NSAIDs or anticoagulants including low dose heparin. Renal function may be worsened when used with ciclosporin or triamterene. Altered absorption when given with sucralfate, colestyramine or colestipol. Ophthalmic application of diclofenac may reduce the efficacy of ophthalmic acetylcholine and carbachol. Increased risk of GI ulceration and bleeding when used with corticosteroids, aspirin or anticoagulants.<BR/> <B>Potentially Hazardous Interaction: </B>Increases blood levels of digoxin, lithium and methotrexate. Potentiate potassium-sparing diuretics.</td></tr><tr><td class="monograph-heading ui-widget-content"><span style="font-weight: bold">Mechanism of action</span></td><td class="ui-widget-content">Diclofenac has potent anti-inflammatory, analgesic and antipyretic actions. It inhibits the enzyme, cyclooxygenase, thus resulting in reduced synthesis of prostaglandin precursors.<BR><B>Absorption: </B>Rapidly absorbed (oral solution, rectal suppository, IM); more slowly (enteric-coated tab).<BR><B>Distribution: </B>Penetrates synovial fluid; enters breast milk (small amounts). Protein-binding: &amp;gt;99%.<BR><B>Metabolism: </B>Extensively hepatic; converted to metabolites.<BR><B>Excretion: </B>About 60% excreted in urine as glucuronide and sulfate conjugates; 35% in bile; 1-2 hr (elimination half-life).</td></tr><tr><td class="monograph-heading ui-widget-content"><span style="font-weight: bold">Food Interaction</span></td><td class="ui-widget-content">Slow absorption of enteric-coated tab when given with food.</td></tr><tr><td class="monograph-heading ui-widget-content"><span style="font-weight: bold">MIMS Class</span></td><td class="ui-widget-content">Ophthalmic Decongestants, Anesthetics, Anti-inflammatoriesNonsteroidal Anti-inflammatory Drugs (NSAIDs)</td></tr><tr><td class="monograph-heading ui-widget-content"><span style="font-weight: bold">ATC Classification</span></td><td class="ui-widget-content">M01AB05 - diclofenac; Belongs to the class of acetic acid derivatives and related substances of non-steroidal antiinflammatory and antirheumatic products. Used in the treatment of inflammation and rheumatism.<BR>M02AA15 - diclofenac; Belongs to the class of non-steroidal antiinflammatory preparations for topical use. Used in the treatment of joint and muscular pains.<BR>S01BC03 - diclofenac; Belongs to the class of non-steroidal antiinflammatory agents. Used in the treatment of inflammation of the eye.<BR></td></tr></table><h4 class="subheading"></h4><table class="ui-widget monograph"><tr><td class="monograph-heading ui-widget-content"><span style="font-weight: bold">Dosage</span></td><td class="ui-widget-content"><I>Oral</I><BR><B>Sprains</B><BR><B><I>Adult: </I></B>As sodium: 75-150 mg daily in divided doses. Max: 150 mg/day.<BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Oral</I><BR><B>Strains</B><BR><B><I>Adult: </I></B>As sodium: 75-150 mg daily in divided doses. Max: 150 mg/day.<BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Oral</I><BR><B> Tendinitis</B><BR><B><I>Adult: </I></B>As sodium: 75-150 mg daily in divided doses. Max: 150 mg/day.<BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Oral</I><BR><B> Pain and inflammation associated with musculoskeletal and joint disorders</B><BR><B><I>Adult: </I></B>As sodium: 75-150 mg daily in divided doses. Max: 150 mg/day.<BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Oral</I><BR><B> Bursitis</B><BR><B><I>Adult: </I></B>As sodium: 75-150 mg daily in divided doses. Max: 150 mg/day.<BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Oral</I><BR><B>Acute gout</B><BR><B><I>Adult: </I></B>As sodium: 75-150 mg daily in divided doses. Max: 150 mg/day.<BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Oral</I><BR><B> Dysmenorrhoea</B><BR><B><I>Adult: </I></B>As sodium: 75-150 mg daily in divided doses. Max: 150 mg/day.<BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Oral</I><BR><B> Migraine</B><BR><B><I>Adult: </I></B>As potassium: Initially, 50 mg taken at the 1st sign of an attack, an additional dose of 50 mg may be taken after 2 hr if symptoms persist. If needed, further doses of 50 mg may be taken every 4-6 hr. Max: 200 mg/day. <BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Intravenous</I><BR><B>Postoperative pain</B><BR><B><I>Adult: </I></B>As sodium: 75 mg infusion in 5% glucose or 0.9% sodium chloride given over 30-120 minutes, may repeat after 4-6 hr if necessary.<BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Intramuscular</I><BR><B>Bursitis</B><BR><B><I>Adult: </I></B>As sodium: 75 mg once daily, injected into the gluteal muscle, may increase to 75 mg bid in severe conditions.<BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Intramuscular</I><BR><B>Sprains</B><BR><B><I>Adult: </I></B>As sodium: 75 mg once daily, injected into the gluteal muscle, may increase to 75 mg bid in severe conditions.<BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Intramuscular</I><BR><B>Strains</B><BR><B><I>Adult: </I></B>As sodium: 75 mg once daily, injected into the gluteal muscle, may increase to 75 mg bid in severe conditions.<BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Intramuscular</I><BR><B>Tendinitis</B><BR><B><I>Adult: </I></B>As sodium: 75 mg once daily, injected into the gluteal muscle, may increase to 75 mg bid in severe conditions.<BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Intramuscular</I><BR><B>Pain and inflammation associated with musculoskeletal and joint disorders</B><BR><B><I>Adult: </I></B>As sodium: 75 mg once daily, injected into the gluteal muscle, may increase to 75 mg bid in severe conditions.<BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Intramuscular</I><BR><B>Acute gout</B><BR><B><I>Adult: </I></B>As sodium: 75 mg once daily, injected into the gluteal muscle, may increase to 75 mg bid in severe conditions.<BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Intramuscular</I><BR><B>Dysmenorrhoea</B><BR><B><I>Adult: </I></B>As sodium: 75 mg once daily, injected into the gluteal muscle, may increase to 75 mg bid in severe conditions.<BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Intramuscular</I><BR><B>Renal colic</B><BR><B><I>Adult: </I></B>As sodium: 75 mg, may repeat once after 30 minutes if needed. Max: 150 mg/day.<BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Intravenous</I><BR><B>Prophylaxis of postoperative pain</B><BR><B><I>Adult: </I></B>As sodium: 25-50 mg infusion given after surgery over 15-60 minutes followed by 5 mg/hr. Max: 150 mg daily.<BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Ophthalmic</I><BR><B>Postoperative ocular inflammation</B><BR><B><I>Adult: </I></B>As sodium (0.1% solution): Instill into the appropriate eye 4 times daily starting 24 hr after surgery for up to 28 days.<BR><I>Ophthalmic</I><BR><B>Prophylaxis of intra-operative miosis</B><BR><B><I>Adult: </I></B>As sodium (0.1% solution): Instill into the appropriate eye 4 times within 2 hr before surgery.<BR><I>Ophthalmic</I><BR><B>Post-photorefractive keratectomy pain</B><BR><B><I>Adult: </I></B>As sodium (0.1% solution): Instill into the eye twice in the hr before surgery, then 1 drop twice at 5-minute intervals immediately after surgery, then every 2-5 hr while awake for up to 24 hr.<BR><I>Ophthalmic</I><BR><B>Seasonal allergic conjunctivitis</B><BR><B><I>Adult: </I></B>As sodium (0.1% solution): Instill 1 drop into the affected eye(s) up to 4 times daily. <BR><I>Ophthalmic</I><BR><B>Pain and discomfort after radial keratotomy</B><BR><B><I>Adult: </I></B>As sodium (0.1% solution): Instill 1 drop before surgery followed by 1 drop immediately after surgery, and then 1 drop 4 times daily for up to 2 days.  <BR><I>Ophthalmic</I><BR><B>Control of inflammation after argon laser trabeculoplasty</B><BR><B><I>Adult: </I></B>As sodium (0.1% solution): Instill 1 drop 4 times during the 2 hr before procedure followed by 1 drop 4 times daily,  up to 7 days after procedure. <BR><I>Ophthalmic</I><BR><B>Inflammation and discomfort after strabismus surgery</B><BR><B><I>Adult: </I></B>As sodium (0.1% solution): Instill 1 drop 4 times daily for the 1st wk; then tid in the 2nd wk, bid in the 3rd wk, and as required for the 4th wk. <BR><I>Ophthalmic</I><BR><B>Pain after accidental trauma</B><BR><B><I>Adult: </I></B>As sodium (0.1% solution): Instill 1 drop 4 times daily for up to 2 days. <BR><I>Topical/Cutaneous</I><BR><B>Local symptomatic relief of pain and inflammation</B><BR><B><I>Adult: </I></B>As sodium (1% gel): Apply onto affected area 3-4 times daily. <BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Topical/Cutaneous</I><BR><B> Osteoarthritis</B><BR><B><I>Adult: </I></B>As sodium (1.6% solution): Apply in small amounts (20-40 drops) onto affected area 4 times daily. <BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Topical/Cutaneous</I><BR><B>Actinic keratoses</B><BR><B><I>Adult: </I></B>As sodium (3% gel): Apply bid for 60-90 days. <BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed. <BR><I>Rectal</I><BR><B>Postoperative pain</B><BR><B><I>Adult: </I></B>75-150 mg daily, in divided doses (25 mg, 50 mg and 100 mg suppositories only). Max: 150 mg/day (inclusive of diclofenac administered through other routes). <BR><B><I>Child: </I></B>6-12 yr: 1-2 mg/kg/day in divided doses (12.5 mg and 25 mg suppositories only) for max of 4 days. <BR><B><I>Hepatic impairment: </I></B>Dose adjustment may be needed.</td></tr><tr><td class="monograph-heading ui-widget-content"><span style="font-weight: bold">Administration</span></td><td class="ui-widget-content">Should be taken with food. (Take immediately after meals.)<br></td></tr><tr><td class="monograph-heading ui-widget-content"><span style="font-weight: bold">Contraindications</span></td><td class="ui-widget-content">Active peptic ulcer; hypersensitivity to diclofenac or other NSAIDs. Treatment of perioperative pain in CABG surgery. 3rd trimester of pregnancy. Topical: Not to be applied onto damaged or nonintact skin.</td></tr><tr><td class="monograph-heading ui-widget-content"><span style="font-weight: bold">Special precautions</span></td><td class="ui-widget-content">History of GI ulceration; impaired cardiac, renal or hepatic function; hypertension; lactation. IV admin in patients with moderate or severe renal impairment; hypovolaemia or dehydration; asthma, porphyria. Monitor LFTs in patients on prolonged therapy. May prolong bleeding time; caution when used in patients with coagulation disorders or on anticoagulants. Prolonged therapy may increase risk of anaemia. 1st and 2nd trimester of pregnancy. Elderly, debilitated patients.</td></tr><tr><td class="monograph-heading ui-widget-content"><span style="font-weight: bold">Adverse reactions</span></td><td class="ui-widget-content">GI disturbances; headache, dizziness, rash; GI bleeding, peptic ulceration; abnormalities of kidney function. Pain and tissue damage at Inj site (IM); local irritation (rectal); transient burning and stinging (ophthalmic).<BR/> <B>Potentially Life-Threatening Adverse Drug Reaction: </B>Stevens-Johnson syndrome, exfoliative dermatitis, toxic epidermal necrolysis.</td></tr><tr><td class="monograph-heading ui-widget-content"><span style="font-weight: bold">Drug interactions</span></td><td class="ui-widget-content">Not to be given IV to patients who are receiving other NSAIDs or anticoagulants including low dose heparin. Renal function may be worsened when used with ciclosporin or triamterene. Altered absorption when given with sucralfate, colestyramine or colestipol. Ophthalmic application of diclofenac may reduce the efficacy of ophthalmic acetylcholine and carbachol. Increased risk of GI ulceration and bleeding when used with corticosteroids, aspirin or anticoagulants.<BR/> <B>Potentially Hazardous Interaction: </B>Increases blood levels of digoxin, lithium and methotrexate. Potentiate potassium-sparing diuretics.</td></tr><tr><td class="monograph-heading ui-widget-content"><span style="font-weight: bold">Mechanism of action</span></td><td class="ui-widget-content">Diclofenac has potent anti-inflammatory, analgesic and antipyretic actions. It inhibits the enzyme, cyclooxygenase, thus resulting in reduced synthesis of prostaglandin precursors.<BR><B>Absorption: </B>Rapidly absorbed (oral solution, rectal suppository, IM); more slowly (enteric-coated tab).<BR><B>Distribution: </B>Penetrates synovial fluid; enters breast milk (small amounts). Protein-binding: &amp;gt;99%.<BR><B>Metabolism: </B>Extensively hepatic; converted to metabolites.<BR><B>Excretion: </B>About 60% excreted in urine as glucuronide and sulfate conjugates; 35% in bile; 1-2 hr (elimination half-life).</td></tr><tr><td class="monograph-heading ui-widget-content"><span style="font-weight: bold">Food Interaction</span></td><td class="ui-widget-content">Slow absorption of enteric-coated tab when given with food.</td></tr><tr><td class="monograph-heading ui-widget-content"><span style="font-weight: bold">MIMS Class</span></td><td class="ui-widget-content">Ophthalmic Decongestants, Anesthetics, Anti-inflammatoriesNonsteroidal Anti-inflammatory Drugs (NSAIDs)</td></tr><tr><td class="monograph-heading ui-widget-content"><span style="font-weight: bold">ATC Classification</span></td><td class="ui-widget-content">M01AB05 - diclofenac; Belongs to the class of acetic acid derivatives and related substances of non-steroidal antiinflammatory and antirheumatic products. Used in the treatment of inflammation and rheumatism.<BR>M02AA15 - diclofenac; Belongs to the class of non-steroidal antiinflammatory preparations for topical use. Used in the treatment of joint and muscular pains.<BR>S01BC03 - diclofenac; Belongs to the class of non-steroidal antiinflammatory agents. Used in the treatment of inflammation of the eye.<BR></td></tr></table></div></div></body></html>